Drugs / Rabies
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04056117 | Sep 2019 → Sep 2022 | shigellosis | LimmaTech Biologics AG | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01662440 | Aug → Dec 2012 | Japanese encephalitis, rabies | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabies | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01662440 ↗ |
| Modality | Vaccine | “a purified chick embryo cell culture rabies vaccine” PMID 26994987 ↗ Mar 2016 |